Home » Topics » Regulatory

Regulatory
RSS

Kalbitor approved in U.S. for hereditary angioedema

Dec. 3, 2009

FDA approves Cymbalta for maintenance treatment of GAD

Dec. 1, 2009

Angiox approved in E.U. for additional indication

Dec. 1, 2009

France grants marketing authorization to Sanofi's Panenza influenza vaccine

Nov. 18, 2009

FDA approves Lysteda for the treatment of menorrhagia

Nov. 17, 2009

Shire launches Intuniv in the U.S. for ADHD in children and adolescents

Nov. 9, 2009

FDA approves Gloucester's Istodax for cutaneous T-cell lymphoma

Nov. 9, 2009

Novartis' influenza A(H1N1) vaccine Celtura approved in Germany

Nov. 6, 2009

Canadian marketing approval for BioMimetic Therapeutics' Augment Bone Graft

Nov. 5, 2009

FDA grants accelerated approval to GSK and Genmab's Arzerra antibody in CLL

Oct. 28, 2009